Beelen, Karin
Opdam, Mark
Severson, Tesa
Koornstra, Rutger
Vincent, Andrew
Wesseling, Jelle
Sanders, Joyce
Vermorken, Jan
van Diest, Paul
Linn, Sabine http://orcid.org/0000-0001-5541-0347
Funding for this research was provided by:
TI-pharma (T3-502)
Stichting A Sister's Hope (4400-41200)
Article History
Received: 21 August 2017
Accepted: 18 May 2018
First Online: 24 July 2018
Ethics approval and consent to participate
: The original trial was approved by the central ethics committee of the Netherlands Cancer Institute and written informed consent was obtained from all study participants. For this retrospective translational study, no additional consent was required according to Dutch legislation [ CitationRef removed ], since the use of archival pathology left-over material does not interfere with patient care. Tumor tissue was handled according to the Dutch code of conduct for dealing responsibly with human tissue in the context of health research [ CitationRef removed ].
: The authors declare that they have no competing interests. The manuscript is part of a PhD thesis.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.